Venture Capital in Luxembourg – Credit Agricole Investor Services Bank Luxembourg

Crédit Agricole Private Equity’s Venture Capital division is continuing to build up its Biotechnology portfolio. Created four years ago under the leadership of Dr Philippe Guinot, MD, PhD, the portfolio currently comprises 12 companies based in Europe, mostly in France. These investments have been made in partnership with established investors such as Sofinova, Healthcap, Index Venture, Axa PE and Sgam. Crédit Agricole Private Equity’s main areas of interest are new therapeutic approaches in cancer, asthma and infectious diseases, as well as opportunities in the production, medical technology and innovative pharmaceuticals sectors. © Crédit Agricole